0000748268-25-000010
SEC filingRevenue surged 646% to $9.6M driven by US Army SRR drone deliveries, though net loss widened 29% to $16.0M.
For the three months ended September 30, 2025, Red Cat Holdings reported a dramatic revenue increase of 646% year-over-year to $9.65 million, driven by initial deliveries of drones under the US Army's SRR program. Gross profit turned positive from a loss of $0.39 million to $0.64 million, with gross margin improving to 7% from -30% in the prior year, aided by higher revenue and lower warranty expense. However, operating expenses surged, with R&D rising 218% to $5.97 million, sales and marketing up 52% to $2.98 million, and general and administrative expenses increasing 124% to $9.22 million, primarily due to higher headcount and stock-based compensation (up 184% to $3.62 million). Other income of $2.21 million, including a $2.45 million gain on extinguishment of convertible notes payable, partially offset expenses. Net loss from continuing operations widened 29% to $16.02 million.
The company operates as a single reporting segment in the drone technology space, serving military, government, and commercial customers. The primary momentum driver is the US Army SRR contract, which contributed substantially to revenue growth. The product mix is transitioning from the Teal 2 to the Black Widow drone, which led to inventory write-offs and lower gross profit in the nine-month period. Management notes that the revenue and margin profile will continue to be influenced by this transition and program deliveries.
The MD&A does not provide explicit forward guidance, but the strong revenue growth from the SRR program indicates near-term momentum. The company’s cash position of $206.4 million and working capital of $224.9 million provide liquidity to fund operations and product development. However, increasing operating expenses and the shift to the Black Widow may pressure margins until production scales. The significant financing activity suggests potential for further investment in growth.
Cash and cash equivalents surged to $206.4 million at September 30, 2025, from $9.2 million at December 31, 2024, primarily driven by net proceeds of $162.6 million from a September 2025 registered direct offering and additional capital from earlier public offerings. Total assets reached $286.0 million, up from $55.6 million. The company’s working capital (current assets minus current liabilities) improved to $224.9 million, eliminating any substantial doubt about its ability to continue as a going concern. Total debt consists of $350,000 in demand notes (Pelion Note) and $13.4 million in convertible notes payable (fair value). Shareholders’ equity rose to $253.3 million from $50.1 million, reflecting the equity raises and accumulated deficit of $177.2 million.
The company has operating lease commitments for real estate with total future payments of $16.9 million as of September 30, 2025. Payments due within one year are $293,288; between one and three years, $3.1 million; and beyond three years, $13.5 million. The weighted-average remaining lease term is 6.28 years, and the weighted-average discount rate is 12%. No finance leases are outstanding. The company also has a warranty liability of $483,052 and contract liabilities of $270. No material litigation reserves have been recorded.
No share repurchase program or dividends were disclosed. Capital expenditures totaled $1.25 million for the nine months ended September 30, 2025, representing 8.6% of revenue. Debt activity included the issuance of a $16.5 million convertible note in February 2025 (amended to $18.15 million), with $1.65 million redeemed in cash and $12.4 million converted into common stock during the period. The company recorded a $2.4 million gain on extinguishment of convertible notes. Proceeds from stock option exercises were $1.46 million, and warrant exercises contributed $2.59 million.
The company operates as a single operating segment. The chief operating decision maker evaluates performance on a consolidated net income basis. No segment-level revenue, operating income, or geographic mix is disclosed in the notes. Revenue is disaggregated into product-related ($12.2 million) and contract-related ($2.3 million) for the nine months ended September 30, 2025.
Operating cash flow (CFO) for the nine months ended September 30, 2025 was -$52.7 million, compared to -$14.7 million in the prior period. The significant deterioration was driven by a net loss of $52.4 million (from continuing operations) and adverse working capital changes. Key adjustments included non-cash items such as stock-based compensation ($7.3M), amortization ($1.2M), depreciation ($0.5M), and a convertible notes fair value adjustment ($12.9M). However, these were offset by large increases in accounts receivable ($5.6M), inventory ($9.7M), prepaid inventory ($7.3M), and prepaid expenses ($4.0M), indicating substantial cash tied up in operations. Capital expenditures (capex) were $1.2 million, up from $0.1 million. The company did not report free cash flow, but CFO minus capex implies a deficit of $53.9M. Financing activities injected $251.2 million, largely from public stock offerings ($249.2M) after costs ($14.9M), convertible note issuances ($15.0M), and exercise of options and warrants ($4.0M). There were no share repurchases or dividends. The cash position surged to $206.4 million from $9.2 million at the start of the period. The cash flow statement reflects a high burn rate in operations offset by substantial equity financing.